Establishment of canine and feline cells expressing canine signaling lymphocyte activation molecule for canine distemper virus study

Veterinary Microbiology

Volumn 133, Issue 1-2, 2009, Pages 179-183

  Nakano, Hitoshi ^a   Kameo, Yuki ^a   Andoh, Kiyohiko ^a   Ohno, Yoshito ^a   Mochizuki, Masami ^b   Maeda, Ken ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b Kyoritsu Seiyaku Corporation   (Japan)

Author keywords

Canine distemper virus; SLAM

Indexed keywords

CD150 ANTIGEN; VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIOPHAGE; CANINE DISTEMPER MORBILLIVIRUS; CONTROLLED STUDY; DOG; GENOTYPE; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONDERSTEPOORT; SEROLOGY; SERUM; VIROLOGY; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD; CATS; DISTEMPER VIRUS, CANINE; DOGS; GENOTYPE; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; VIRUS CULTIVATION;

CANINE DISTEMPER VIRUS; CANIS FAMILIARIS; FELIDAE;

EID: 55549083493     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.06.016     Document Type: Article

References (14)

1. Appel M.J. Pathogenesis of canine distemper. Am. J. Vet. Res. 30 (1969) 1167-1182
2. Hamburger D., Griot C., Zurbriggen A., Orvell C., and Vandevelde M. Loss of virulence of canine distemper virus is associated with a structural change recognized by a monoclonal antibody. Experia 47 (1991) 842-845
3. Kai C., Ochikubo F., Okita M., Iinuma T., Mikami T., Kobune F., and Yamanouchi K. Use of B95a cells for isolation of canine distemper virus from clinical cases. J. Vet. Med. Sci. 55 (1993) 1067-1070
4. Lan N.T., Yamaguchi R., Inomata A., Furuya Y., Uchida K., Sugano S., and Tateyama S. Comparative analyses of canine distemper viral isolates from clinical cases of canine distemper in vaccinated dogs. Vet. Microbiol. 115 (2006) 32-42
5. Lednicky J.A., Meehan T.P., Kinsel M.J., Dubach J., Hungerford L.L., Sarich N.A., Witecki K.E., Braid M.D., Pedrak C., and Houde C.M. Effective primary isolation of wild-type canine distemper virus in MDCK, MV1 Lu and Vero cells without nucleotide sequence changes within the entire haemagglutinin protein gene and in subgenomic sections of the fusion and phospho protein genes. J. Virol. Methods 118 (2004) 147-157
6. Mochizuki M., Hashimoto M., Hagiwara S., Yoshida Y., and Ishiguro S. Genotypes of canine distemper virus determined by analysis of the hemagglutinin genes of recent isolates from dogs in Japan. J. Clin. Microbiol. 37 (1999) 2936-2942
7. Mochizuki M., Motoyoshi M., Maeda K., and Kai K. Complement-mediated neutralization of canine distemper virus in vitro: cross-reaction between vaccine Onderstepoort and field KDK-1 strains with different hemagglutinin gene characteristics. Clin. Diagn. Lab. Immunol. 9 (2002) 921-924
8. Myers D.L., Zurbriggen A., Lutz H., and Pospischil A. Distemper: not a new disease in lions and tigers. Clin. Diagn. Lab. Immunol. 4 (1997) 180-184
9. Nakaichi M., Taura Y., Kanki M., Mamba K., Momoi Y., Tsujimoto H., and Nakama S. Establishment and characterization of a new canine B-cell leukemia cell line. J. Vet. Med. Sci. 58 (1996) 469-471
10. Nielsen L., Andersen M.K., Jensen T.D., Blixenkrone-Moller M., and Bolt G. Changes in the receptor-binding haemagglutinin protein of wild-type morbilliviruses are not required for adaptation to Vero cells. Virus Genes 27 (2003) 157-162
11. Plattet P., Rivals J.P., Zuber B., Brunner J.M., Zurbriggen A., and Wittek R. The fusion protein of wild-type canine distemper virus is a major determinant of persistent infection. Virology 337 (2005) 312-326
12. Plattet P., Zweifel C., Wiederkehr C., Belloy L., Cherpillod P., Zuebriggem A., and Wittek R. Recovery of a persistent canine distemper virus expressing the enhanced green fluorescent protein from cloned cDNA. Virus Res. 101 (2004) 147-153
13. Seki F., Ono N., Yamaguchi R., and Yanagi Y. Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J. Virol. 77 (2003) 9943-9950
14. Tatsuo H., Ono N., and Yanagi Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J. Virol. 75 (2001) 5842-5850